
Featured news
15 Dec 2025
Cannabis derivatives could provide new ovarian cancer treatments
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells

Featured news
15 Dec 2025
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells

Featured news
07 Nov 2025
Over 800 million people globally have a type of diabetes, with numbers steadily rising. November 14 marks World Diabetes Day. We’re highlighting five recently published articles on aging and diabetes.

Featured news
15 Jul 2025
Guest editorial by Rachael Frost, a senior lecturer at Liverpool John Moores University and author of a new Frontiers in Pharmacology article.

Featured news
07 Dec 2022
by Angharad Brewer Gillham, Frontiers science writer Image/Shutterstock.com Polish scientists revealed the potential for new cancer drugs to be formulated from bioactive compounds found in plants from the genus Solanum, like potatoes and aubergines. Everyone knows someone who has had cancer. In 2020, around 19m new cases — and around 10m deaths — were registered worldwide. Treatments are improving all the time but can damage healthy cells or have severe side-effects which are hard on patients; in the search for new, more targeted cancer drugs, traditional medicine offers many possible candidates. A team of Polish scientists led by Magdalena Winkiel at Adam Mickiewicz University, publishing today in Frontiers in Pharmacology, reviewed the bioactive compounds called glycolalkaloids that are found in many vegetables that are household names, like potatoes and tomatoes, to demonstrate their potential to treat cancer. “Scientists around the world are still searching for the drugs which will be lethal to cancer cells but at the same time safe for healthy cells,” said Winkiel. “It is not easy despite the advances in medicine and powerful development of modern treatment techniques. That is why it might be worth going back to medicinal plants that were used years ago with success […]

Featured news
12 Sep 2022
By Conn Hastings, science writer Image: Shutterstock.com There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction network to identify whether existing drugs could provide a new treatment approach. The researchers discovered that a common anti-diarrheal drug may have potential in treating the social difficulties associated with ASD. Can you teach an old drug new tricks? Although drug treatments for the core symptoms of autism spectrum disorder (ASD) are not currently available, could an existing drug provide a new treatment, even if it previously had no association with ASD? This was the question asked by a new study in the journal Frontiers in Pharmacology. The researchers used a computer model that encompasses proteins involved in ASD and the way they interact. By looking at how different drugs affected proteins in the system, they identified potential candidates to treat it. A commonly used antidiarrheal drug called loperamide was the most promising candidate, and the researchers have an interesting hypothesis about how it may work to treat ASD symptoms. Some of the most common symptoms in ASD involve difficulties with social interaction […]

Frontiers news
23 Aug 2019
Dr Ameenah Gurib-Fakim, former President of Mauritius joins Editorial Board of Ethnopharmacology in Frontiers in Pharmacology

Frontiers news
26 Nov 2018
Frontiers in Pharmacology publishes 4000th article

Frontiers news
22 Oct 2018
A new collaboration with the International Natural Product Sciences Taskforce (INPST) explores the science behind natural products and promotes science communication

Frontiers news
27 Jun 2018
The latest Frontiers in Pharmacology section promotes cutting-edge discoveries contributing to the goal of eliminating renal dialyses and deaths from kidney diseases.

Frontiers news
16 Apr 2018
The article, on the role of adenosine receptors in Amyotrophic Lateral Sclerosis (or motor neuron disease), comes from scientists at the University of Lisbon, Portugal.

Featured news
12 Apr 2018
Low caffeine doses worsened neophobia, anxiety-related behaviors and emotional and cognitive flexibility: Frontiers in Pharmacology

Frontiers news
07 Nov 2017
Professor Heike Wulff appointed as new Field Chief Editor for the journal.

Frontiers news
28 Jun 2017
Frontiers in Pharmacology continues to rank among the world’s top pharmacology journals in terms of influence and quality.

Life sciences
22 Jun 2017
Japanese scientists develop a new technique to isolate active therapeutic compounds for Alzheimer’s disease from plants.

Life sciences
22 Mar 2017
Computer modelling suggests that drug combinations could protect from long-term drug level reductions in certain patients after a break from anti-cancer drug.
Get the latest research updates, subscribe to our newsletter